Interventional oncology

News

CLOCC Study Final Results: Does Local Treatment Increase Survival Time?

07/07/2017

Patients with unresectable colorectal liver metastases survive longer if they are treated with a combination of systemic treatment and local treatment with radiofrequency ablation and with or without resection, according to the final results...

Patients with unresectable...

07/07/2017

IO Learning

Interview

Takeaways From the Latest Clinical Trial Data

07/05/2017

Ripal Gandhi, MD, practices interventional oncology at the Miami Cardiac and Vascular Institute and Miami Cancer Institute and is a Course Director for the Symposium on Clinical Interventional Oncology (CIO). Dr. Gandhi closely follows the...

Ripal Gandhi, MD, practices...

07/05/2017

IO Learning

Interview

Charles Ray, MD, PhD: Tips for Managing an Interventional Oncology Practice

06/28/2017

Running an interventional oncology practice is a challenging endeavor that draws on multiple skill sets, from communicating with colleagues to implementing measures to assess and improve quality. IO360 interviewed Charles Ray, MD, PhD, about...

Running an interventional...

06/28/2017

IO Learning

News

How Many Days of Doxorubicin Delivery Can DEE Transarterial Chemoembolization Provide?

06/21/2017

Drug-eluting embolic (DEE) transarterial chemoembolization agents are able to deliver doxorubicin to targeted tissues even 80 days after chemoembolization, according to a study published in the June JVIR. Hadrien D’inca, PhD, and colleagues,...

Drug-eluting embolic (DEE)...

06/21/2017

IO Learning

News

Researchers Compare Antibiotic Prophylactic Regimens for Infection Prevention After Hepatic Embolotherapy

06/15/2017

Antibiotic prophylaxis does not appear to reduce the risk of infectious complications after embolotherapy in patients who have previously undergone biliary procedures, according to an abstract presented at the 2017 World Conference on...

Antibiotic prophylaxis does not...

06/15/2017

IO Learning

News

Is Segmental Radioembolization for Localized HCC More Effective Than Segmental Chemoembolization?

06/15/2017

Patients who undergo segmental radioembolization for localized, unresectable hepatocellular carcinoma (HCC) have higher complete response rates and local tumor control than those treated with segmental chemoembolization, researchers reported...

Patients who undergo segmental...

06/15/2017

IO Learning

News

Certain Home Medications May Improve Survival After Locoregional Therapy

06/14/2017

Taking aspirin, other nonsteroidal anti-inflammatory (NSAID) drugs, or beta blockers at the time of liver tumor embolization is linked with better survival rates, according to an abstract presented at the 2017 World Conference on...

Taking aspirin, other...

06/14/2017

IO Learning

Clinical Insights

From the CIO Dailies: How to Build and Nurture an Interventional Oncology Practice

05/09/2017

Timothy Clark, MD An interview with Timothy Clark, MD, Director, Interventional Radiology, Penn Presbyterian Medical Center, Division of Interventional Radiology, Department of Radiology, University of Pennsylvania. Why did you choose to...

Timothy Clark, MD An...

05/09/2017

IO Learning

News

Metactive Medical Announces Issuance of Patents on Blockstent and Ballstent Embolization Devices

03/21/2017

OLATHE, Kan. – March 21, 2017 - Metactive Medical Inc. (Metactive), an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, today announced the issuance of US...

OLATHE, Kan. – March 21, 2017 -...

03/21/2017

IO Learning

Research Roundup in Interventional Oncology

03/20/2017

By Amanda Harvey

Interventional oncology is a rapidly advancing field for interventional radiologists. These image-guided and minimally invasive procedures are increasing patient quality of life through easier recoveries with less burdensome procedures,...

Interventional oncology is a...

03/20/2017

IO Learning